Stanley Druckenmiller Recursion Pharmaceuticals, Inc. Transaction History

Duquesne Family Office LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.59 - $15.86 $3.16 Million - $7.6 Million	-479,183 Reduced 34.57%	906,767 $6.94 Million
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $8.71 Million - $15.1 Million	1,112,300 Added 406.47%	1,385,950 $14.7 Million
Q1 2022 May 16, 2022	BUY	$6.16 - $18.03 $84,447 - $247,173	13,709 Added 5.27%	273,650 $1.96 Million
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $4.95 Million - $10.7 Million	259,941 New	259,941 $5.98 Million

257

191M

787K

1.52M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.7B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Duquesne Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Duquesne Family Office LLC and Stanley Druckenmiller with notifications on news.